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Anthropometrically estimated total body water volumes are larger
than modeled urea volume in chronic hemodialysis patients:
Effects of age, race, and gender.
Background. The modeled volume of urea distribution (Vm)
in intermittently hemodialyzed patients is often compared with
total body water (TBW) volume predicted from population
studies of patient anthropometrics (Vant).
Methods. Using data from the HEMO Study, we compared
Vm determined by both blood-side and dialysate-side urea
kinetic models with Vant as calculated by the Watson, Hume-
Weyers, and Chertow anthropometric equations.
Results. Median levels of dialysate-based Vm and blood-
based Vm agreed (43% and 44% of body weight, respectively).
These volumes were lower than anthropometric estimates of
TBW, which had median values of 52% to 55% of body weight
for the three formulas evaluated. The difference between the
Watson equation for TBW and modeled urea volume was
greater in Caucasians (19%) than in African Americans (13%).
Correlations between Vm and Vant determined by each of the
three anthropometric estimation equations were similar; but
Vant derived from the Watson formula had a slightly higher
correlation with Vm. The difference between Vm and the an-
thropometric formulas was greatest with the Chertow equation,
less with the Hume-Weyers formula, and least with the Watson
estimate. The age term in the Watson equation for men that
adjusts Vant downward with increasing age reduced an age
effect on the difference between Vant and Vm in men.
Conclusion. The findings show that kinetically derived val-
ues for V from blood-side and dialysate-side modeling are
similar, and that these modeled urea volumes are lower by a
substantial amount than anthropometric estimates of TBW.
The higher values for anthropometry-derived TBW in hemodi-
alyzed patients could be due to measurement errors. However,
the possibility exists that TBW space is contracted in patients
with end-stage renal disease (ESRD) or that the TBW space
and the urea distribution space are not identical.
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Mathematical modeling of urea kinetics during and
between intermittent hemodialyses allows calculation of
the urea distribution volume. The volume is calculated by
computing the amount of urea nitrogen removed during
a dialysis treatment and then dividing by the consequent
reduction in serum urea nitrogen. For example, if one
computes that during a given treatment 21 g of urea nitro-
gen has been removed, and that the resulting urea reduc-
tion due to this treatment is 0.7 g/L, one can infer that the
volume of urea distribution is 30 L. The urea distribution
volume computed in this fashion is called the modeled
volume (Vm) and is commonly expressed as a postdial-
ysis value. Vm can be monitored in a given patient over
time to guide changes in the dialysis prescription and to
clarify the cause of shortfalls in delivered therapy [1].
Urea is believed to distribute in the total body water
[2, 3], which can be estimated from formulas based on
various combinations of the patient’s height, weight, gen-
der, and age and sometimes other factors. When estimat-
ing an initial dialysis prescription for patients, clinicians
often compute the initial dose of dialysis using one of
these anthropometric formulas (Vant). These prediction
equations have been derived by various means. The
widely used equation by Watson, Watson, and Blatt [4]
was based on a meta-analysis of previous studies where
total body water was estimated using a variety of dilution
techniques and markers of water volume. The equation
derived by Hume and Weyers [5] and Du Bois and Du
Bois [6] was derived using tritiated water as a marker.
An equation proposed by Chertow et al [7] was based
on bioimpedance measurements. Whereas the Watson
and Hume-Weyers equations were based on data in non-
dialysis subjects, the Chertow equation was derived from
a population with end-stage renal disease (ESRD).
Several authors who have examined this issue critically
have found that the modeled urea distribution volume in
hemodialysis patients is lower than the water volume pre-
dicted by anthropometric equations [8–13]. However, a
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formal double-pool urea kinetic model was not used in
all such studies [8, 9], and in several of these papers,
dialysate-side Vm was markedly lower than blood-side
Vm. The purpose of the present study was to compare
the modeled urea distribution volume with anthropo-
metric estimates of total body water in patients enrolled
in the National Institutes of Health (NIH) Hemodialysis
(HEMO) Study, applying double-pool modeling con-
cepts in a large number of patients.
METHODS
The NIH HEMO Study
The NIH HEMO Study was a prospective, random-
ized, multicenter clinical trial designed to study survival,
hospitalizations, and a number of secondary end points
in patients randomized to different levels of dialysis dose
and membrane flux [14]. Using a 2  2 factorial design,
half of the qualifying patients were dialyzed with a target
equilibrated Kt/V (eKt/V) of 1.45 [20-second postdialysis
urea reduction ratio (URR) about 75%] and half were
treated with a target eKt/V of 1.05 (20-second postdial-
ysis URR about 67%). In each group, half of the patients
were dialyzed using low-flux membranes, and half were
dialyzed using high-flux membranes.
Entry criteria for the HEMO Study included a three-
dialyses-per-week schedule of dialysis for at least 3
months, aged 18 to 80 years, residual renal clearance
1.5 mL/min per 35 L of urea volume, and anticipated
ability to achieve a target eKt/V of 1.45 during a 41⁄2-
hour dialysis [14, 15]. Because of this last entry criteria,
very large patients were likely excluded from the HEMO
Study, although centers had the opportunity to test
whether or not a high target eKt/V could be achieved
during a baseline, prerandomization phase of the trial.
Baseline period. During this baseline period, two mod-
eling sessions were performed while patients received
their prestudy dialysis prescription. This gave baseline
adequacy information as well as an initial estimate of
each patient’s urea distribution volume. The patients
were then studied during at least two additional dialysis
sessions using one of the approved HEMO Study dialyz-
ers (the clearances of which had been characterized both
in vitro and in vivo) in which blood flow rate, dialysate
flow rate, and session length had been adjusted to at-
tempt to achieve a target eKt/V of 1.45. If the target
eKt/V could not be reliably achieved, patients were not
randomized into the follow-up phase of the study.
During the baseline period, modeling depended on a
predialysis blood urea nitrogen (BUN) and a 20-second
postdialysis BUN only. No delayed postdialysis BUN
samples were drawn, and urea removal in the dialysate
was not quantified.
Follow-up session (F4) methods. After randomization,
half of the patients were maintained on the high-goal
prescription with a target eKt/V of 1.45, whereas in the
remainder the prescription was set to a target eKt/V
of 1.05 (URR about 0.65). During follow-up, patients
underwent monthly predialysis and postdialysis BUN
determinations that were used to compute single-pool
Kt/V (spKt/V) and eKt/V. During month 4 of follow-up
(F4), a more intensive modeling session was scheduled
for all patients. During this particular session, additional
blood samples were drawn 1 hour into dialysis, including
dialyzer blood inflow and outflow samples, and a delayed
blood sample was taken 30 minutes after dialysis in addi-
tion to the usual 20-second postdialysis sample to permit
better extrapolation of postdialysis urea rebound.
In a substudy of 146 patients at the F4 session, total
urea removed in the spent dialysate was measured with
the Baxter Biostat (Baxter Corp., Deerfield, IL, USA)
[16]. This device calculates the total amount of urea
removed in the spent dialysate from the dialysate flow
rate, ultrafiltration rate, session length, and dialysate out-
flow urea nitrogen concentration measured at 5-minute
intervals in the first 30 minutes of dialysis and at 10-
minute intervals thereafter. The dialysate urea nitrogen
outflow levels combined with the dialysate flow rate were
used to compute total urea nitrogen removed in the
dialysate.
During the Biostat sessions, samples for BUN were
taken predialysis, at 1 hour from the dialyzer blood inlet
and outlet lines, and 20 seconds and 30 minutes after
the completion of dialysis, allowing computation of
equilibrated postdialysis BUN values.
Subjects
Patient data for the present analysis were taken from
both modeling sessions performed at baseline (no de-
layed postdialysis BUN and no dialysate urea values)
and from those sessions at F4 where both dialysate and
blood-side modeling had been performed. A number of
additional inclusion criteria were applied, namely (1)
dialysis via a peripheral arteriovenous (AV) access, (2)
access recirculation15% by the slow-flow urea method
(as per [17], but modified to use a flow reduction to 50
to 80 mL/min for 20 seconds prior to sampling), (3) no
above-the-knee amputation, (4) self-reported race was
Caucasian or African American, (5) the session was con-
ducted on an “official” HEMO Study–approved dialyzer,
(6) valid measurements of predialysis and postdialysis
BUN with the postdialysis BUN between 10% and 60%
of the predialysis BUN, and (7) the patient had at least
three modeling sessions satisfying conditions 1 to 6.
A total of 5308 modeled dialyses in 1124 randomized
patients satisfied these criteria during the baseline pe-
riod. Means of volumes were calculated after excluding
the most deviant volume in cases where the coefficient
of variation was greater than 10%. Patients were retained
for the F4 study if conditions 1 to 6 described above
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were satisfied, the 30-minute postdialysis BUN was ob-
tained, and if no more than two of the individual mea-
surements sampled at 5- to 10-minute intervals by the
Biostat device were identified by that device as invalid.
Urea modeling in the HEMO Study
In the HEMO Study, dialysis treatment adequacy was
assessed using several blood-side and dialysate-side mod-
eling methods [15]. A relatively small number of dialyz-
ers were used, the urea clearance of which were charac-
terized both during in vitro studies and in vivo by
obtaining simultaneous inlet/outlet BUN samples on
many occasions. Postdialysis blood samples, routinely
obtained 15 to 20 seconds after dialysis, were also drawn
30 minutes after dialysis in a subgroup of patients for
dialysate-side urea kinetics [12, 16]. The classic double-
pool, variable volume model of urea kinetic during and
between dialyses was defined by:
d(C1V1)/dt  G Kc(C1 - C2)  C1(Kd  Kr)
d(C2)/dt  Kc(C2 – C1)/V2
dV1/dt  Qf
where C is the concentration of urea, subscript 1 refers
to the proximal dialyzed compartment (nominally taken
to be the extracellular compartment in classic double-
pool modeling) and subscript 2 to the distal equilibrating
compartment (nominally taken to be the intracellular
compartment in classic double-pool modeling), G is the
urea generation rate, Kc is the intercompartment urea
mass transfer coefficient, Kd is the dialyzer urea clear-
ance, Kr is the patient’s native kidney clearance, and Qf
is the rate of fluid loss during dialysis (negative between
dialyses). The volume of the distal equilibrating compart-
ment V2 is assumed to be constant over time and twice
the volume of the proximal compartment at the end of
dialysis. Sensitivity analyses showed that the ratio of the
volumes of the two compartments [V2 ranging from 27%
to 45% of (V1  V2)] had only a trivial effect on calcu-
lated modeled volumes with the modeling method used.
Modeled urea volume (Vmdp) from 30-minute post-BUN
and blood-side modeling. Vmdp was estimated by numeri-
cally curve fitting the above equations for the double-pool
model to BUN measurements obtained predialysis, post-
dialysis (20-second slow-flow method), and 30 minutes
postdialysis [15]. Values for Vm and the intercompartment
mass transfer coefficient (Kc) were selected that provided
maximum agreement between the model BUN predic-
tions and the three measured BUNs. These measure-
ments, which were considered the gold standard (double-
pool modeled volume), were done only during the F4 study.
Details of the methods used to estimate the in vivo dia-
lyzer clearances used are presented separately [18].
Modeled urea volume (Vmsp-adj) from 20-second post-BUN
and blood-side modeling, with appropriate adjustments to
approximate a double-pool volume. Vmsp-adj (single-pool
adjusted) was measured using single-pool, blood-side ki-
netics and was then adjusted to better approximate dou-
ble-pool modeled volume. Single-pool modeled V (Vmsp)
was obtained by applying the two-BUN method of De-
pner and Cheer [19]. This iterative method initially com-
putes an estimated Vmsp based on anthropometric pa-
rameters, and then adjusts the calculated urea generation
rate until the estimated predialysis BUN at steady-state
equals the actual predialysis BUN. After each iteration,
Vmsp is recalculated from standard variable-volume sin-
gle-pool equations, based on the estimated dialyzer
clearance, urea generation rate, ultrafiltration rate, ses-
sion length, and predialysis and postdialysis BUN values.
An estimate of the double-pool V (Vmsp-adj) was then
obtained from Vsp based on a previously determined
estimate of the ratio of single-pool and double-pool V
and the fall in BUN during dialysis:
Vmsp-adj  Vsp / (ln [(F  C0/Ct)]/[F  ln (C0/Ct)])
where Ceq is an estimate of the equilibrated postdialysis
BUN derived from application of the rate equation, C0
and Ct denote the predialysis and postdialysis BUN, and
F Ct /Ceq [20–22]. Measurements of Vmsp-adj were made
during the baseline as well as the F4 period.
For both of the methods described above for measur-
ing V, dialyzer clearance was calculated using the blood
flow adjusted for prepump pressure effects, and the esti-
mated in vivo dialyzer K0A [18, 23].
Modeled urea volume (Vmddq) from Biostat dialysate
urea values, estimated dialysate volume, and from pre-
and 30-minute post-BUN. Vmddq was calculated during
the F4 session using direct dialysate quantification:
Vmddq  (A – G  T – Qf  T  Cpre)/(Cpre  Ceq)
where A is the total urea removed estimated by the Biostat
device, G is the urea generation rate, T the session length,
Qf the ultrafiltrate volume, Ceq the equilibrated post-
dialysis BUN, and Cpre the predialysis BUN. For the direct
dialysate method, Ceq was estimated by applying a nu-
merical curve fit of the predialysis, postdialysis, and 30-
minute postdialysis BUN to the double-pool variable vol-
ume model, similar to that used to estimate Vmdp above.
The predialysis blood specimen was drawn from the
access device before giving saline or heparin. The postdi-
alysis blood samples were drawn 15 to 20 seconds after
slowing the blood pump to 50 to 80 mL/min, and the
delayed postdialysis samples (F4 session only) were ob-
tained 30 minutes after the end of the dialysis session.
During the F4 sessions, even though inlet and outlet
BUN samples were obtained during individual sessions,
for consistency, the population average in vivo dialyzer
mass transfer area coefficient (K0A) was used instead of
a K0A based on the dialyzer inlet/outlet extraction ratio
for each session.
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Calculation of anthropometric volumes
Anthropometric formulas estimate the volume of
body water (V) from gender, weight, height, age, and
diabetic status using the following equations:
Hume-Weyers
Men: V
 14.01  0.2968  weight  0.1948  height
Women: V
 35.27  0.1838  weight  0.3445  height
Watson
Men: V  2.447  0.3362  weight  0.1074  height
 0.09516  age
Women: V
 2.097  0.2466  weight  0.1069  height
where age is in years, height in centimeters, and postdial-
ysis weight in kilograms.
Chertow
V  0.0749 age  1.0178  male  0.127  height
 0.0401  weight  0.579  diabetes  0.000672
 weight2  0.0349  (age  male)  0.1126
 (male  weight)  0.00104  (age  weight)
 0.00186  (height  weight)
where age is in years, height in centimeters, weight refers
to the predialysis weight in kilograms, male is equal to
1 for males and 0 for females, and diabetes is 1 for
diabetics and 0 for nondiabetics.
Note that the Hume-Weyers approximation for V
does not include age. The negative sign for the age term
in the Watson equation indicates a decrease in V with
age in men, but there is no age term for women. The
Chertow equation is designed to compute predialysis V
so for the purposes of this study, the weight loss (obtained
from the dialysis run sheet) was subtracted from the
Chertow V to give a postdialysis value (Adj Chertow).
Statistical analyses
Patient and dialysis characteristics and the volume esti-
mates were summarized for the F4 and the baseline stud-
ies by standard descriptive statistics (e.g., mean, median,
standard deviation). Volume estimates were compared
by presenting the ratio of the mean values of each vol-
ume, with standard errors determined by the delta
method [24]. These comparisons were provided for all
146 patients combined for the F4 study, but for the base-
line data set the sample size (1124) was sufficiently large
to provide the volume comparisons in gender and race
specific subgroups. For the baseline study the difference
Table 1. Patient characteristics for 4-month follow-up study
(N  146 patients)
Mean Median SD
Age years 57.90 58.97 13.65
Post weight kg 71.30 69.50 13.20
Height cm 166.65 166.35 8.87
Race (% African American) 61 — —
Body mass index 25.73 25.25 4.75
Serum creatinine mg/dL 10.88 10.60 2.81
Qb mL/min 378.35 400.0 68.01
Qd mL/min 702.67 800.0 120.70
Td min 210.60 210.0 28.61
spKt/V 1.54 1.56 0.23
eKt/V 1.30 1.36 0.21
URR 0.72 0.72 0.05
Abbreviations are: Qb, blood flow rate; Qd, dialysate flow rate; Td, session
length; spKt/V, single-pool Kt/V; eKt/V, equilibrated Kt/V (derived from spKt/V
and the rate equation); URR, urea reduction ratio.
between Vmsp-adj and each of the three anthropometric
estimates was related to age by using separate semipara-
metric multiple regression analyses in males and females
to relate the difference between Vant and Vmsp-adj to a
cubic spline function of age while controlling for race
and diabetic status. The difference between the anthro-
pometric estimates and Vmsp-adj was also evaluated by
using a multiplicative regression model [25] to relate
Vmsp-adj to a product of Vant with proportional adjust-
ment factors for gender, race, diabetic status, and age.
The association of each of the Vant estimates with
Vmsp-adj was evaluated on a patient basis in terms of the
Pearson R to evaluate linear association, the concor-
dance R [26] to evaluate the overall level of agreement,
incorporating both bias and the degree of linear associa-
tion, and the median absolute error to evaluate overall
agreement. These three statistics were compared between
the anthropometric estimates by applying the bootstrap
method with 800 bootstrap samples [27] to estimate the
standard errors of differences in the statistics between
the respective estimates. All reported P values are two-
sided, and regarded as statistically significant if P  0.05
without adjustment for multiple comparisons.
RESULTS
Follow-up period F4 session results
These results pertain to the modeling sessions per-
formed at F4, 4 months after randomization, where mul-
tiple blood samples during and after dialysis were ob-
tained, including a 30-minute postdialysis BUN sample,
and where the Biostat was used to measure urea in the
spent dialysate.
Patient characteristics. As shown in Table 1, of the
146 patients studied, 39 were Caucasian males, 18 were
Caucasian females, 47 were African American males,
and 42 were African American females. Other races were
excluded from this analysis.
Daugirdas et al: Total body water volumes are larger in hemodialysis patients1112
Table 2. Anthropometric and modeled volumes (liters) N  146 patients
Ratio of mean with respect to
Median V Median V/weight
Mean SD L L/kg Vmddq Vmsp-adj
Watson V 36.61 5.63 36.84 0.52 1.17 1.16
Hume-Weyers V 37.58 5.79 38.09 0.54 1.20 1.19
Adj Chertow Va 37.99 6.36 37.75 0.55 1.22 1.20
Vmdpb 32.05 6.26 31.25 0.45 1.03 0.99
Vmsp-adjc 31.66 6.25 31.21 0.44 1.01 —
Vmddq (Biostat) 31.22 8.10 31.81 0.43 — 0.99
aThe Chertow estimate was adjusted to the postdialysis V
bVmdp includes a blood urea nitrogen (BUN) 30 minutes postdialysis
cVmsp-adj is the single-pool volume based on a slow-flow 20-second postdialysis BUN and adjusted to approximate the double-pool volume (see Methods section)
Fig. 1. Agreement between dialysate-side modeled volume urea distri-
bution (Vmddq) and blood-sided Vmdp. Patients were studied at the F4
session, 4 months into follow-up. The change in urea concentration
was calculated using the equilibrated postdialysis blood urea nitrogen
(BUN) extrapolated from a 30-minute postdialysis sample for both
the blood-side and dialysate-side Vm methods. R denotes the Pearson
correlation. N  146, r  0.62, median  volume  0.01 L.
Anthropometric TBW vs. modeled urea volumes. Ta-
ble 2 shows that the three anthropometric estimates of
V are similar and there were no statistically significant
differences among the three modeled estimates of Vm.
The modeled urea volumes had median volume to weight
ratios (L/kg  100%) of 43% to 45%, whereas the me-
dian anthropometric TBW volume/weight ratios were
52% to 55%. Accordingly, each of the three modeled
urea volume values were substantially and significantly
lower than any of the three anthropometric TBW esti-
mates (P  0.001). The ratios (SE) of the respective
mean estimates of each Vant to mean Vmddq were Watson
V, 1.17 (0.02); Hume-Weyers V, 1.20 (0.02); Adj Chertow
V, 1.22 (0.02); Vmdp 1.03 (0.02); Vmsp-adj 1.01 (0.02). The
ratios with respect to Vmsp-adj were Watson V, 1.16 (0.01);
Fig. 2. Agreement between dialysate-side modeled urea distribution
(Vmddq) and blood-sided Vmsp-adj. Patients were studied at the F4 session,
4 months into follow-up. The change in urea concentration was calculated
using the equilibrated postdialysis blood urea nitrogen (BUN) extrapo-
lated from a 20-second postdialysis sample for the blood-sided Vm method,
and using an equilibrated post-dialysis BUN extrapolated from the 30-
minute postdialysis BUN for the dialysate-side Vm method. R denotes
the Pearson correlation. N  146, r  0.58, median  volume  0.26 L.
Hume-Weyers V, 1.19 (0.01); Adj Chertow V, 1.20 (0.02),
Vmdp 1.01 (0.02).
Agreement among modeled estimates of urea volume
(Vmdp, Vmsp-adj, Vmddq). In Figures 1 and 2, estimates of
urea volume for individual patients computed using
blood-side modeling (vertical axis) are compared to the
dialysate-side (DDQ) estimates (horizontal axis). For
computation of Vmdp shown in Figure 1, the equilibrated
postdialysis BUN was extrapolated from the 30-minute
postdialysis sample using double-pool modeling. The
same value of equilibrated postdialysis BUN was used
to compute Vmddq. In Figure 2, Vmsp-adj is based on extrap-
olating the 20-second postdialysis BUN to an equili-
brated postdialysis BUN as described in the Methods
section. Vmddq values in Figure 2 are identical to the
Vmddq values shown in Figure 1.
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Table 3. Patient and treatment characteristics at baseline, by gender and race
Caucasian males N  232 African American males N  316
Mean Median SD Mean Median SD
Age years 57.76 61.07 15.75 54.53 54.58 13.08
Post weight kg 72.20 70.40 14.12 72.73 70.54 13.55
Height cm 171.46 172.20 7.38 172.04 171.85 7.50
Body mass index 24.55 23.91 4.43 24.58 24.00 4.40
Serum creatinine mg/dL 10.18 10.20 2.57 12.11 11.90 3.23
Qb mL/min 400.59 400.00 39.10 421.32 423.38 41.65
Qd mL/min 661.89 650.00 120.61 700.55 700.00 102.32
Td min 228.35 235.63 21.09 228.39 230.00 20.78
spKt/V 1.62 1.61 0.13 1.59 1.58 0.12
eKt/V 1.39 1.39 0.11 1.37 1.35 0.10
URR 0.73 0.73 0.03 0.73 0.72 0.03
Caucasian females N  167 African American females N  409
Mean Median SD Mean Median SD
Age years 57.95 61.14 14.57 59.28 61.26 12.59
Post weight kg 66.46 63.62 15.67 67.90 67.02 14.48
Height cm 159.14 158.70 7.61 160.45 160.00 6.82
Body mass index 26.34 24.88 6.52 26.38 25.98 5.43
Serum creatinine mg/dL 8.56 8.40 2.08 10.19 10.10 2.57
Qb mL/min 379.21 385.71 50.72 413.51 412.50 41.17
Qd mL/min 644.50 600.00 120.28 675.81 650.00 114.28
Td min 207.96 210.00 22.11 208.38 210.00 22.16
spKt/V 1.73 1.72 0.17 1.71 1.70 0.16
eKt/V 1.46 1.44 0.15 1.44 1.42 0.14
URR 0.76 0.76 0.03 0.75 0.75 0.03
Abbreviations are: Qb, blood flow rate; Qd, dialysate flow rate; Td, session length; spKt/V, single-pool Kt/V; eKt/V, equilibrated Kt/V (derived from spKt/V and
the rate equation); URR, urea reduction ratio.
Baseline period results
For the baseline study a larger sample of 1124 patients
was available, and both anthropometric and modeled
estimates of V were averaged over at least three kinetic
modeling sessions for each patient. However, since dialy-
sate sampling was not done, and only the standard predi-
alysis and postdialysis BUNs were obtained, the modeled
V was computed using only the Vsp-adj technique.
Patient characteristics by gender and race. As shown
in Table 3, 548 male patients and 576 female patients
were analyzed. Among Caucasians, there was a prepon-
derance of males (232) to females (167), whereas this
gender ratio was reversed among African Americans
with 316 males and 409 females. The mean URR was
relatively high (73% to 76%) since several sessions were
set to determine whether or not patients could achieve
the high-goal dialysis prescription.
Anthropometric TBW vs. modeled urea volumes by
gender and race. Table 4 compares the three anthropo-
metric TBW volumes to Vmsp-adj by gender and race. As
expected, all volumes were significantly higher in males
compared to females. For example the median Watson
volume/weight ratio was 55% or 56% in Caucasian and
African American males, respectively, whereas it was
only 48% and 47% in Caucasian and African American
females. It is clear that in all race and gender subgroups,
anthropometric estimates of TBW were markedly higher
than the modeled urea volume, where the median vol-
ume/weight ratios for urea were 46% and 48% in Cauca-
sian and African American males and 40% and 41% in
Caucasian and African American females.
The differences expressed as percents are listed in
Table 5. Here we see that the anthropometric equation
for TBW with the least difference from the modeled
urea volume is the Watson equation, while the Hume-
Weyers equation had the second smallest difference. The
newer TBW equation by Chertow et al tended to be
greater than the modeled V by a slightly greater amount.
The differences between modeled urea volume and an-
thropometric estimates of TBW were significantly greater
in males than in females and were also significantly greater
in Caucasians than in African Americans.
Effects of age and other factors on differences
between anthropometric estimates of TBW and
modeled urea distribution volume
The Watson equation has an age-related term for
males that reduces the predicted value for Vant with
increasing age at a given height and weight. The equation
has no such term for females, as in the original Watson
meta-analysis, a marked age effect in females was not
found. Figures 3 and 4 examine this issue by plotting the
difference between Vant  Vm as a function of patient
age controlling for diabetic status and race, with Figure
3 showing the results for males and Figure 4 for females.
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Table 4. Volume estimates at baseline
Caucasian males N  232 African American males N  316 All males N  548
Median Median Median
Mean V (SD) Median V V/weight Mean V (SD) Median V V/weight Mean V (SD) Median V V/weight
Watson V L 39.63 (5.12) 38.61 0.55 40.17 (4.94) 39.78 0.56 39.94 (5.02) 39.31 0.56
Hume-Weyers V L 40.80 (4.89) 40.22 0.57 41.07 (4.72) 40.67 0.57 40.96 (4.79) 40.44 0.57
Chertow V L 44.76 (5.89) 43.78 0.63 45.23 (5.83) 44.83 0.63 45.03 (5.86) 44.41 0.63
Adj Chertow V L 41.68 (5.58) 40.87 0.58 41.99 (5.51) 41.62 0.58 41.86 (5.53) 41.21 0.58
Vmsp-adj L 33.09 (4.94) 33.03 0.46 34.94 (5.16) 34.52 0.48 34.16 (5.15) 33.85 0.48
Caucasian females N  167 African American females N  409 All females N  576
Median Median Median
Mean V (SD) Median V V/weight Mean V (SD) Median V V/weight Mean V (SD) Median V V/weight
Watson V L 31.30 (4.05) 30.79 0.48 31.81 (3.84) 31.61 0.47 31.66 (3.91) 31.37 0.47
Hume-Weyers V L 31.78 (4.14) 31.80 0.49 32.52 (4.02) 32.14 0.48 32.31 (4.07) 32.04 0.49
Chertow V L 34.68 (4.18) 34.35 0.54 35.44 (4.19) 35.08 0.53 35.22 (4.20) 34.95 0.53
Adj Chertow V L 31.98 (4.01) 31.56 0.49 32.62 (3.99) 32.39 0.49 32.44 (4.01) 32.22 0.49
Vmsp-adj L 26.74 (4.70) 25.85 0.40 28.27 (4.81) 27.82 0.41 27.83 (4.82) 27.34 0.41
Table 5. Percent differences between anthropometric estimates and modeled V (Vmsp-adj) at baselinea
Anthropometric Caucasian males Caucasian females African American African American All patients
V measure (N  232) (N  167) males (N  316) females (N  409) (N  1124)
Watson V 19.80.9 17.11.2 15.00.6 12.50.7 15.50.4
Hume-Weyers V 23.30.9 18.81.3 17.50.7 15.00.7 18.10.4
Adj Chertow V 26.01.0 19.61.3 20.10.7 15.40.7 19.80.4
aPercent differences in meansSE. All percent differences significantly greater than 0 (P  0.001).
Fig. 3. The effect of age on the difference between each of three measures
of anthropometric volume (Vant) and modeled urea volume (Vmsp-adj)
in men.
Inspection of Figure 3 shows that the differences be-
tween Vant  Vm is similar for the Watson equation
for males across age, although it does increase slightly
with age. This suggests that the age term in the Watson
equation has the benefit of making more constant the
difference between its predicted volume and modeled
urea volume across age. With the other anthropometric
estimates of TBW, the difference between Vant and Vm
tends to increase with age, especially in men.
Fig. 4. The effect of age on the difference between each of three measures
of anthropometric volume (Vant) and modeled urea volume (Vmsp-adj) in
women.
In Figure 4, the difference between anthropometric
estimates of TBW and modeled urea volume increases
to a lesser extent with age in females. This suggests
that the performance of the Watson equation V is only
slightly reduced by its lack of an age term for females.
Table 6 shows how the three anthropometric measures
of total body water (Watson, Hume-Weyers, adjusted
Chertow) relate to the modeled urea volume (as Vmsp-adj)
and how this relationship is affected by diabetes, age,
gender, and race.
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Table 6. Multiplicative regressions of Vmsp-adj vs. Vant at baseline
Estimate of Vant
Factor Watson Hume-Weyers Adjusted Chertow
Overall multiple of Vant (AESRD) 0.824 (0.006)a 0.815 (0.006)a 0.796 (0.005)a
Adjustment for diabetes (Adiab) 1.033 (0.007)a 1.039 (0.007)a 1.023 (0.007)b
Age adjustment per 10 years in men (Aage.m) 0.998 (0.004) 0.977 (0.003)a 0.982 (0.003)a
Age adjustment per 10 years in women (Aage.f) 0.985 (0.004)a 0.992 (0.004)b 0.988 (0.004)b
Adjustment for female gender (Afemale) 1.033 (0.008)a 1.014 (0.008) 1.045 (0.008)a
Adjustment for African American race (AAf-Am) 1.043 (0.007)a 1.039 (0.008)a 1.041 (0.008)a
RMSE (L) 3.47 3.56 3.56
Shown are coefficients (SE) for regression models of the form: Vm  Vant  AESRD  [Adiab  if diabetic]  [Aage.m  (Age  50) if male]  [Aage.f  (Age  50)
if female]  [Afemale if female]  [AAf-Am if African American]. RMSE (root mean square error) estimates the standard deviation of the errors of the regression
models in predicting Vm.
a Different than 1, P  0.001; b different than 1, P  0.05
The first term, AESRD, indicates the multiplier of Vant
necessary to estimate the mean Vm for nondiabetic Cau-
casian males of age 50 years, and the remaining terms
indicate proportional adjustments for gender, African
American race, diabetes, and age. These proportionality
constants can be used to construct a prediction equation
based on the HEMO Study data for the urea distribution
volume starting with any of the well-accepted anthropo-
metric total body water volumes. RMSE is the square
root of the mean squared error and is a measure of the
overall fit of each anthropometric volume to the modeled
urea volume (Vm).
The AESRD terms, listed in the top row, are less than
1.0 for each of the anthropometric volumes tested. The
second row is a term for diabetes and indicates that
the urea volume is about 2% to 4% higher in diabetics
relative to the anthropometric body water predictions.
The next two rows depict age adjustments. Some of the
TBW equations have an age term, others do not. The
adjustment factors shown suggest that urea volume de-
clines with age, and that this adjustment is made by some
of the TBW equations (e.g., Watson) better than others,
and also, that this age adjustment is gender-dependent.
The additional rows suggest added terms for gender and
race to improve the prediction of Vm from each of the
anthropometric equations. As can be seen from the last
row, which shows the root mean squared error, overall,
the Watson equation gave the closest agreement with
the modeled urea volume.
These proportionality terms can be used to obtain a
new prediction equation for Vm based on anthropomet-
ric TBW equations. For example, we can use the Watson
equation as a starting point and then the full model from
Table 6 for estimating Vmsp-adj from the Watson TBW
volume is:
Vm  [Watson V]  [0.824]  [1.033 if diabetic]
 [0.998  (age  50) if male]
 [0.985  (age  50) if female]
Table 7. Agreement of anthropometric estimates of V with Vmsp-adj
at baseline
Pearson Concordance Median absolute
R R % error vs. Vm
All patients
Watson V 0.799 0.606 16.5%
Chertow V 0.786a 0.531a 20.9%a
Hume-Weyers V 0.779a 0.544a 18.7%a
Males
Watson V 0.711 0.431 17.2%
Chertow V 0.699 0.342a 20.0%a
Hume-Weyers V 0.685a 0.353a 22.6%a
Females
Watson V 0.695 0.492 15.9%
Chertow V 0.671a 0.428a 18.9%a
Hume-Weyers V 0.651a 0.427a 17.8%a
aAgreement of indicated anthropometric formula with Vmsp-adj was significantly
(P  0.05) poorer than the agreement of Watson V with Vmsp-adj
 [1.033 if female]
 [1.043 if African American]
If the gender and age terms are omitted from the
model, the regression equation estimating Vmsp-adj from
the Watson V is:
Vm  [Watson V]  [0.828]
 [1.045 if African American]
 [1.032 if diabetic]
The RMSE for this simpler model is 3.50, which is
only slightly higher than the RMSE of 3.47 for the com-
plete model shown in Table 6.
Association of anthropometric estimates of TBW with
modeled urea V on a patient basis
Table 7 summarizes the association of the anthropo-
metric estimates of TBW with Vmsp-adj on a patient basis
for the baseline study. The Pearson R values summarize
the strength of the linear association of the estimates
independently of the systematic underestimation of
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Vmsp-adj by the anthropometric estimates, the concor-
dance R incorporates both bias and the strength of linear
association, and the median absolute percent error is a
measure of the overall agreement. The results suggest
that, overall, the Watson equation had a slightly smaller
divergence from modeled Vmsp-adj than the other two
equations.
DISCUSSION
Our results showed that modeled urea V was substan-
tially lower than total body water predicted by each of
three equations based on anthropometric measurements.
We found that the median volume to weight ratios (liter
per kilogram, as percent) for modeled urea volume were
48% and 41% for men and women, respectively, whereas
Watson volume to weight ratios were 56% and 47%,
similar to previously published data. In this respect, our
findings confirm those of Pastan and Gassensmith [8],
reported in 1992 in a much smaller sample of patients.
Other investigators who have examined the issue closely
have also found urea distribution volume to be lower
than anthropometric total body water estimates [8–13],
although the shortfall was not always of the magnitude
found in the present study.
Despite the contention that urea distribution volume
is equal to TBW, there are few papers in the literature
where urea distribution space has been measured using
isotopes, and almost none where measurements using
both urea and water isotopes have been made in the same
patients. In an early paper from 1953, using 15N-labeled
urea, San Pietro and Rittenberg [2] measured the urea
volume and found a volume to weight ratio of 48% to
50% in three nondialysis subjects. They also measured
volume with both 15N-labeled urea and deuterium oxide
in a female patient and found that the urea volume was
similar to water volume, albeit 5% lower. Pearson et al
[28] injected doubly labeled (15N and 13C) urea to six
ESRD patients and five control subjects. They found
mean urea volume/weight ratios of 50% in the ESRD
patients (five females and one male) and 58% in the
nondialysis controls (three females and one male). Klop-
penburg et al [3], in a methods paper, gave 13C urea
to one nondialysis volunteer and one ESRD patient,
genders of both unspecified. In the ESRD patient, the
urea volume/weight ratio was 52%, whereas in the nondi-
alysis patient the mean urea volume/weight ratio was
62%. The same group then went on to study a larger
number of patients, and obtained both DDQ-modeled
urea volumes and, in a subset of patients, 13C urea vol-
umes [9]. The volume/weight ratios of their DDQ-mod-
eled urea volumes (44% and 38% for males and females,
respectively) were somewhat smaller than our values of
48% and 41%. In a subset of male patients with both
DDQ and 13C urea volumes, the volume/weight ratios
were 48% for DDQ and 52% for 13C urea. Thus, our
results are not inconsistent with previous investigators
who have measured urea space in ESRD patients using
isotopes or mathematic modeling.
The apparently lower urea distribution volume found
in our study might have resulted from underestimation of
the amount of urea removed. In the blood-side modeling
method, we employed a blood flow correction algorithm
that down-regulated the estimated blood flow rate from
the nominal flow rate derived from the blood pump rota-
tional speed. At nominal blood flow rates of 200, 300, 400,
and 500 mL/min, our algorithm predicted mean delivered
blood flow rates of 200, 296, 375, and 418 mL/min, respec-
tively. The derivation and rationale for this blood flow
adjustment algorithm are discussed in a separate paper
[18]. These adjustments are consistent with several previ-
ous studies that demonstrate significant overestimation
of flow at high blood flow rates by the rotational speed
meters found in all dialysis roller pumps [18, 23]. For
the blood tubing used by most of the HEMO Study
centers, we found a similar error but of lower magnitude
when flows were measured in vitro with warmed saline
(unpublished data). In a sensitivity analysis, when we
used the lesser corrections determined by the in vitro
saline studies (a lowest case scenario), we found that the
percent difference between mean Watson V and Vm
was 12.4%, which is similar to the 15.5% reported in
Table 5.
The agreement in the average amount of urea removed
between our double-pool blood-side modeling analysis
and dialysate recovery methods in the substudy at 4 months
follow-up suggests that a substantial underestimation of
urea removed was unlikely, although the possibility re-
mains that urea removal was underestimated by both
blood- and dialysate-side modeling methods.
Overestimation of the change in patient urea concen-
tration during dialysis is another potential source of er-
ror. Although the amount of urea removed in our pa-
tients was computed using different methods, the same
reduction in urea concentration was used for each method.
If the extrapolated postdialysis BUN was underesti-
mated, then the change in concentration would be over-
estimated, resulting in an inappropriately low Vm. In a
separate HEMO substudy, we compared our extrapola-
tion methods for equilibrated postdialysis BUN from 20-
second and 30-minute postdialysis samples with a sample
obtained 60 minutes postdialysis and found excellent
agreement (HEMO Study Investigators, unpublished re-
sults). Furthermore, no investigator has found a large
rebound in urea concentration occurring beyond 60 min-
utes postdialysis [11, 13]. For these reasons, we believe
that underestimation of the equilibrated postdialysis
BUN leading to underestimation of Vm is unlikely. Re-
cently, in an American Society of Nephrology abstract
presented at the 2001 Annual Meeting of the American
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Society of Nephrology (abstract #A2367; Jorden M et al,
Nephrology; Pediatrics, University Hospital Groningen,
The Netherlands) the Groningen group did report appar-
ent excretion of urea into the gastrointestinal tract in
dialysis patients. If a gastrointestinal repository of urea
does exist in dialysis patients, and if it is relatively resis-
tant to extraction during relatively short-session hemodi-
alysis, but less resistant to equilibration with isotope-
labeled water, then this might account for some of the
discrepancy between modeled urea volumes found in
our study with TBW estimates.
Another factor that might lead to differences between
anthropometric TBW estimates and modeled urea vol-
umes in our study would be a difference in body composi-
tion between patients with normal renal function and
dialysis patients. Two of the prediction equations (Wat-
son and Hume-Weyers) were derived from data in nondi-
alysis individuals, so it could be argued that uremia-
mediated effects on body composition caused the true
TBW to be reduced in such patients, and that the differ-
ence between estimated TBW and modeled urea volume
in our study is more apparent than real. The impedance
data of Cha et al [29] argue against this premise. The
Chertow formula was derived from measurements of
body impedance in dialysis patients and was calibrated
against deuterium oxide dilution. The Chertow predic-
tion equation for TBW in our patients (corrected to the
postdialysis condition) gave results that were quite similar
to TBW predicted by either the Watson and Hume-
Weyers equations, and these values were still substan-
tially higher than the modeled urea volumes found.
It is unclear whether modeled urea volume in our
patients was simply underestimated, or whether there
may be a true difference between TBW and urea distri-
bution volumes. Others who also have found urea distri-
bution volume to be lower than TBW estimates have
argued that there may be errors in the isotopic determi-
nation of TBW from which some of these anthropomet-
ric estimating equations were derived. For example, with
any water-soluble isotope, if one fails to correct the iso-
tope concentration in the dilution sample for plasma
water, this will lead to an approximately 7% overestima-
tion of TBW [9] since only 93% of plasma, on average,
is water. Another potential source of overestimation of
TBW by deuterium or tritium is proton-proton exchange
with nonwater hydrogen-containing molecules in the
body. It is not clear to what extent these errors may have
been present in the “calibration” of currently used TBW
estimating equations. The Watson prediction equations
were derived from a meta-analysis of previous papers
[4], each of which measured TBW by several different
methods. The Hume-Weyers equations are based on
measurements using tritiated water [5]. In neither one
of these papers is there mention of making a blood water
correction. Cha et al calibrated their bioimpedance mea-
surements against deuterated water [29], and apparently
the plasma water correction was made in their paper,
and the issue of hydrogen self-exchange was recognized
and corrected.
Our data also shed light on the need for and appropri-
ateness of gender- and age-related correction factors for
some of the anthropometric estimating equations. Our
results suggest that, in males, modeled urea distribution
volume Vm declines with age, as predicted by the Watson
equations, but that Vm also declines with age in females,
albeit to a lesser extent. Body composition is known to
change with age, with a reduction in muscle mass and
increase in fat mass. Given the greater muscularity of
young males, this age effect should be more easily mea-
sured in males. Our results also suggest that the Watson
equations give the closest approximation to Vm in the
present dialysis population, and that the age term in the
Watson equation properly corrects for age-related bias.
Although the Chertow equation also contains age-related
terms, it did not correct for the age-effect in males as
well as the Watson equation.
Our data further highlight the need for correcting an-
thropometric prediction equations based on race and,
perhaps, diabetes. It is now well known that African
American patients tend to have a higher rate of creati-
nine excretion relative to Caucasians after controlling
for age, weight, and height [30]. The difference appears
to be a racial effect favoring higher muscle mass in Afri-
can American patients [31]. A relatively higher muscle
mass would, of course, also be reflected in a greater ratio
of TBW to weight/height/age for African Americans.
Hence, our results suggesting that the difference between
anthropometric equations and modeled urea volumes
is less in African Americans than in Caucasians is not
surprising. Reinterpreted, these results suggest that, for
a given age, height, and weight, African Americans have
a higher true urea V (Vm) than their Caucasian counter-
parts. Recently Chumlea et al [32] have found similar
results for TBW using deuterated or tritiated water mea-
surements in a nondialysis population. The race bias
appeared to be slightly higher in males than in females.
These findings suggest that any prediction equation for
urea V in dialysis patients should incorporate a correc-
tion for race. We also found a small correction factor
for diabetes, suggesting that the presence of diabetes
results in a 3% to 4% increase in modeled V. The need
for a correction factor for diabetes was recognized by
Chertow et al, although the magnitude of our correction
factor was somewhat larger. Why diabetics might have
higher TBW values and even higher urea volumes than
predicted is unknown. One hypothesis might relate to
cardiovascular disease and autonomic neuropathy, re-
sulting in difficulties in achieving so-called dry weight.
In the past, overestimation of Vm has not invalidated
the dialysis prescription, since dialyzer urea clearance
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based on in vitro estimates is routinely overestimated
[8]. Hence, prescribing the amount of dialysis based on
in vitro dialyzer urea clearance and anthropometrically
estimated V remains a sound practice. However, when
dialyzer clearance is more precisely measured, and when
the appropriate double-pool corrections are applied, our
data suggest that a substantial difference between mod-
eled urea Vm and anthropometrically derived TBW that
is race and gender dependent, is to be expected. If the
in vivo dialyzer urea clearance is known or derived from
the dialysis machine, it might be better to modify the
Watson V or whatever anthropometric equation is used
according to the appropriate prediction equations in Ta-
ble 6 to give a more reliable initial estimate of the urea
distribution volume (although the exclusion of very large
patients from the HEMO Study by design should be
kept in mind).
CONCLUSION
Our results provide further evidence that commonly
used equations to predict the TBW markedly overestimate
the urea distribution volume in dialysis patients. To what
extent this represents (1) a true difference between the
urea distribution space vs. TBW in dialysis patients, (2)
a measurement error in modeled urea volume, possibly
due to gastrointestinal urea sequestration, (3) a measure-
ment error in TBW determined by indicator dilution
using deuterium, tritium, or other isotopes in the studies
from which common estimating equations were derived,
or (4) an alteration in body composition in patients with
ESRD must remain the object of future studies.
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APPENDIX: ESTIMATION OF IN VIVO
DIALYZER CLEARANCES
In vivo dialyzer clearances used in this study were calculated as
follows. First, the in vivo KoA was estimated using the equation:
K0A  	KoA  [1  	Qd(Qd  500)/300  	reuse (Eq. 1)
 (reuse number)]
where 	KoA represents the in vivo K0A of the dialyzer model at first
use with Qd  500 mL/min, 	Qd characterizes the effect of increasing
Qd from 500 to 800 mL/min on the in vivo K0A [8], and 	reuse character-
izes the effect of the number of reuses under the assumption that the
effect of reuse on the in vivo KoA is proportional to the number of
reuses within the observed range of Qd. The true Qb was estimated
by the formula
Qb  Qbn  
A  Qbn  ((Qbn 200)/100)
B (Eq. 2)
where Qbn denotes the nominal blood flow from the pump speed. The
values of the 	KoA, 	Qd, 	reuse, 
A,, and 
B in Eq. 1 and Eq. 2 were obtained
by fitting a nonlinear regression model to the observed extraction ratios
(defined as (Cin Cout)/Cin,where Cin and Cout represent the inlet and
outlet BUN concentrations at full blood flow 1 hour into dialysis) for
1208 patients on arteriovenous accesses. The estimates were as follows:
Parameter Estimate
	KoA
Fresenius F8 625
Fresenius F80 651
Baxter CT-190G 751
Baxter CA-210 682
Baxter CA-170 498
Fresenius F50 426
Primus 2000 583
Fresenius F6 489

A 0.0122

B 2.37
	Qd 0.0549
	reuse 0.0063
Given (Eq. 1) and (Eq. 2) with the values of the parameters in the
above table, the dialyzer clearance Kd was determined at each of the
kinetic modeling sessions considered in this report by the formula:
Kd
 0.894  Qb  e
K0A
Qb
1
Qb
Qd
  1
e
K0A
Qb
1
Qb
Qd
  Qb
Qd
  (1  Qf/(0.894  Qb) Qf
where Qf denotes the ultrafiltration rate.
REFERENCES
1. Daugirdas JT: Chronic dialysis prescription, in Handbook of Dial-
ysis, edited by Daugirdas JT, Blake PG, Ing TS, Philadelphia,
Lippincott Williams & Wilkins, 2000
2. San Pietro A, Rittenberg D: A study of the rate of protein
synthesis in humans. I. Measurement of the urea pool and urea
space. J Biol Chem 201:445–456, 1953
3. Kloppenburg WD, Wolthers BG, Stellaard F, et al: Determina-
tion of urea kinetics by isotope dilution with [13-C]urea and gas
chromatography-isotope ratio mass spectrometry (GC-IRMS)
analysis. Clin Sci (Lond) 93:73–80, 1997
4. Watson PE, Watson ID, Blatt RD: Total body water volumes
for adult males and females estimated from simple anthropometric
measurements. Am J Clin Nutr 33:27–29, 1980
5. Hume R, Weyers E: Relationship betwen total body water and
surface area in normal and obese subjects. J Clin Pathol 24:234–238,
1971
6. Du Bois D, Du Bois EF: A formula to estimate the approximate
surface area if height and weight are known. Arch Intern Med
17:863–971, 1916
7. Chertow GM, Lazarus JM, Lew NL, et al: Development of a
population-specific regression equation to estimate total body wa-
ter in hemodialysis patients. Kidney Int 51:1578–1582, 1997
8. Pastan S, Gassensmith C. Total body water measured by bioelec-
trical impedance in patients after hemodialysis. Comparison with
urea kinetics. ASAIO J 38:M186–M189, 1992
9. Kloppenburg WD, Stegeman CA, De Jong PE, Huisman M. An-
thropometry-based equations overestimate the urea distribution
volume in hemodialysis patients. Kidney Int 59:1165–1174, 2001
10. Bankhead MM, Toto RD, Star RA: Accuracy of urea removal
estimated by kinetic models. Kidney Int 48:785–793, 1995
11. Tattersall JE, DeTakats D, Chamney P, et al: The post-hemodi-
alysis rebound: predicting and quantifying its effect on Kt/V. Kid-
ney Int 50:2094–2102, 1996
12. Argiles A, Ficheux A, Thomas M, et al: Precise quantification of
Daugirdas et al: Total body water volumes are larger in hemodialysis patients 1119
dialysis using continuous sampling of spent dialysate and total
dialysate volume measurement. Kidney Int 52:530–537, 1997
13. Schneditz D, Fariyike B, Osheroff R, Levin NW: Is intercom-
partmental urea clearance during hemodialysis a perfusion term?
A comparison of two pool urea kinetic models. J Am Soc Nephrol
6:1360–1370, 1995
14. Greene T, Beck GJ, Gassman JJ, et al: Design and statistical issues
of the hemodialysis (HEMO) study. Control Clin Trials 21:502–525,
2000
15. Daugirdas JT, Depner TA, Gotch FA, et al: Comparison of meth-
ods to predict equilibrated Kt/V in the HEMO Pilot Study. Kidney
Int 52:1395–1405, 1997
16. Depner TA, Greene T, Gotch FA, et al: Imprecision of the hemo-
dialysis dose when measured directly from urea removal. Hemodi-
alysis Study Group. Kidney Int 55:635–647, 1999
17. Daugirdas JT, Burke MS, Balter P, et al: Screening for extreme
postdialysis urea rebound using the Smye method: Patients with
access recirculation identified when a slow flow method is not used
to draw the postdialysis blood. Am J Kidney Dis 28:727–731, 1996
18. Depner TA, Greene T, Daugirdas JT, et al, for the Hemodialysis
(HEMO) Study Group: Dialyzer performance in the HEMO
Study: In vivo KOA and true blood flow determined from a model
of cross dialyzer urea extraction (submitted for publication)
19. Depner TA, Cheer A: Modeling urea kinetics with two vs. three
BUN measurements. A critical comparison. ASAIO Trans 35:499–
502, 1989
20. Daugirdas JT, Schneditz D: Overestimation of hemodialysis dose
depends on dialysis efficiency by regional blood flow but not by
conventional two pool urea kinetic analysis. ASAIO J 41:M719–
M724, 1995
21. Daugirdas JT, Smye SW: Effect of a two compartment distribution
on apparent urea distribution volume. Kidney Int 51:1270–1273,
1997
22. Daugirdas JT, Greene T, Depner TA, et al: Relationship between
apparent (single-pool) and true (double-pool) urea distribution
volume. Kidney Int 56:1928–1933, 1999
23. Depner TA, Rizwan S, Stasi TA: Pressure effects on roller pump
blood flow during hemodialysis. ASAIO Trans 36:M456–M459,
1990
24. Cox C: Encyclopedia of Biostatistics, volume 2, edited by Armitage
P, Colton T, New York, Wiley, 1998, pp 1125–1127
25. PROC NLIN, from SAS/STAT Users Guide: SAS OnlineDoc, Ver-
sion 8, Cary, NC, SAS Institute Inc., 1999
26. Lin LIK: A concordance correlation coefficient to evaluate repro-
ducibility. Biometrics 45:255–268, 1989
27. Effron B, Tibshirani RJ: An Introduction to the Bootstrap (Chap-
ters 5 and 6), New York, Chapman & Hall, 1993
28. Pearson P, Lew S, Abramson F, Bosch J: Measurement of kinetic
parameters for urea in end-stage renal disease patients using a
two-compartment model. J Am Soc Nephrol 4:1869–1873, 1994
29. Cha K, Chertow GM, Gonzalez J, et al: Multifrequency bioelec-
trical impedance estimates the distribution of body water. J Appl
Physiol 79:1316–1319, 1995
30. Levey AS, Bosch JP, Lewis JB, et al: A more accurate method
to estimate glomerular filtration rate from serum creatinine: A
new prediction equation. Modification of Diet in Renal Disease
Study Group. Ann Intern Med 130:461–470, 1999
31. Lee RC, Wang Z, Heo M, et al: Total-body skeletal muscle mass:
development and cross-validation of anthropometric prediction
models. Am J Clin Nutr 72:796–803, 2000
32. Chumlea WC, Guo SS, Zeller CM, et al: Related articles: Total
body water reference values and prediction equations for adults.
Kidney Int 59:2250–2258, 2001
